Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs)
$72.25
neg -0.75
-1.03%
Today's Range: 71.84 - 72.99 | ENDP Avg Daily Volume: 2,120,000
Last Update: 12/22/14 - 4:00 PM EST
Volume: 1,087,645
YTD Performance: 8.21%
Open: $72.55
Previous Close: $73.00
52 Week Range: $53.62 - $82.16
Oustanding Shares: 153,713,243
Market Cap: 10,962,828,491
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 8
Moderate Buy 1 1 2 2
Hold 4 4 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 1.64 1.64 1.79 2.03
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -6.81
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-6.81 0.00 25.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.83% 10.69% 112.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue -13.60 0.52 0.15
Net Income 0.00 -2.87 0.00
EPS 0.00 -3.71 0.00
Earnings for ENDP:
EBITDA 0.88B
Revenue 2.62B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.12 $1.24 $4.23 $4.61
Number of Analysts 12 2 14 13
High Estimate $1.21 $1.25 $4.36 $5.06
Low Estimate $1.08 $1.23 $4.03 $4.20
Prior Year $0.96 $0.92 $4.79 $4.23
Growth Rate (Year over Year) 16.41% 34.78% -11.77% 9.18%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | Nov 25, 2014 | 2:30 PM EST

Whether it's acquiring or the acquired, Mylan is building shareholder value.

bullishEndo Health Solutions upgraded at Cantor Fitzgerald

Oct 13, 2014 | 7:54 AM EDT

ENDP upgraded to Hold, said Cantor Fitzgerald. Auxilium deal should be accretive to EPS with longer term increases in EBITDA, possibly facilitating additional M&A. 

bullishEndo upgraded at Morgan Stanley

May 2, 2014 | 8:10 AM EDT

ENDP was upgraded from Equal-weight to Overweight, Morgan Stanley said. $79 price target. Mesh settlement removes a multi-billion dollar liability. 

bullishEndo Health Solutions price target raised at UBS

Mar 3, 2014 | 7:47 AM EST

ENDP bumped up its number, UBS said. Driven by continud performance of base business and potential for accretive deals. $90 price target and Buy rating. 

By

Herb Greenberg

 | Jan 15, 2014 | 9:00 AM EST

This rollup name is on the stock-market equivalent of steroids.

bearishEndo Health downgraded at Cantor

Jan 2, 2014 | 7:51 AM EST

ENDP was downgraded to Sell, Cantor Fitzgerald said. $43 price target. Company may struggle to cut more operating costs. 

bullishEndo Health upgraded at Cantor

Nov 6, 2013 | 8:11 AM EST

ENDP was upgraded to Hold, Cantor Fitzgerald said. $54 price target. Company boosted guidance, but appears fully valued. 

bullishEndo Health upgraded at Needham

Nov 6, 2013 | 7:39 AM EST

ENDP was upgraded Underperform to Hold, Needham said. Valuation call. 

bullishEndo numbers raised at UBS

Sep 20, 2013 | 8:19 AM EDT

ENDP earnings estimates were raised to include the Boca deal, said UBS. Price target goes to $50.

bullishEndo numbers raised at UBS

Aug 7, 2013 | 8:07 AM EDT

ENDP estimates were raised with Qualitest on track and cost efficiencies are achieved, said UBS. Price target goes to $43.

Under Armour has been fading since the opening bell. The stock is off just shy of 1.6...
I wrote on RMP last week that I thought CVS Health (CVS) was too pricey. Today independent...
Shares of Lockheed Martin are pushing further into new all time high ground. LMT is...
We are feeling the pain today with our long GILD calls, these things happen and is why we ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.